SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,854 | +5.9% | 700 | 0.0% | 0.08% | +6.9% |
| Q2 2023 | $80,164 | -48.9% | 700 | -93.5% | 0.07% | -7.7% |
| Q3 2021 | $157,000 | +37.7% | 10,700 | 0.0% | 0.08% | +77.3% |
| Q2 2021 | $114,000 | -12.3% | 10,700 | 0.0% | 0.04% | -10.2% |
| Q1 2021 | $130,000 | -20.2% | 10,700 | -48.3% | 0.05% | -18.3% |
| Q4 2020 | $163,000 | +44.2% | 20,700 | 0.0% | 0.06% | +33.3% |
| Q3 2020 | $113,000 | -83.1% | 20,700 | +31.8% | 0.04% | -87.4% |
| Q1 2020 | $670,000 | -14.1% | 15,700 | 0.0% | 0.36% | -4.0% |
| Q4 2019 | $780,000 | – | 15,700 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |